HRMY P/E ratio: current value, 10-year range and year-by-year history
Cash & Leverage
HRMY's p/e ratio is lower than 65% of the last 10 years.
P/E ratio History
HRMY P/E ratio by year
Yearly range of HRMY’s p/e ratio from 2020 to 2026. Over the full period it ranged from -316.1 to 223.7, averaging 15.1.
| Year | Low | Average | High | Year-end |
|---|---|---|---|---|
| 2026 | 9.8 | 12.4 | 14.3 | 12.5 |
| 2025 | 8.1 | 12.0 | 16.1 | 13.8 |
| 2024 | 12.5 | 15.6 | 20.4 | 13.7 |
| 2023 | 7.8 | 12.1 | 18.2 | 13.1 |
| 2022 | 17.3 | 49.5 | 88.2 | 21.5 |
| 2021 | -316.1 | 0.9 | 223.7 | 73.5 |
| 2020 | -32.1 | -18.5 | -11.7 | -32.1 |
Get notified when HRMY P/E ratio crosses a threshold
Free — one alert setup, notifications by push, Telegram, or Discord.
How much the market pays for each dollar of annual profit. P/E = Stock Price / EPS. The raw number means little — what matters is whether it's high or low relative to the company's own history.
Price / Earnings Per ShareThe chart shows five color-coded historical zones: green (below 10th percentile) means historically very cheap, fading through lime and gray (the normal 25th–75th range) to orange and red (historically expensive). When the line sits in a green or lime zone, the stock is trading at an unusually low P/E relative to its own history.
- Cyclical businesses look cheapest on P/E at peak earnings — the "earnings trap." Use EV/EBITDA or normalised earnings for energy, materials, and financials.
- A falling P/E trend may signal a business in structural decline, not a buying opportunity.
Is HRMY P/E ratio High or Low Right Now?
Harmony Biosciences Holdings, Inc.'s P/E ratio is currently 12.5, which is below average relative to its 10-year historical range. The 10-year median P/E ratio for HRMY is approximately 13.3. See all HRMY valuation metrics →
Unlock 10y, 15y, 20y, and 30y history with peer comparison and CSV export.